Assyro AI

FDA Orange Book · active-ingredient family

Mechlorethamine hydrochloride

Mechlorethamine hydrochloride is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:VALCHLOR · NDA 202317

2

Brand (NDA)

0

Generics (ANDA)

6

Listed patents

0

Exclusivity periods

Brand (NDA) products · gel, injectable

ProductApplicantApplicationTEApproved
VALCHLORRLDHELSINNNDA 202317Aug 23, 2013
MUSTARGENRLDRECORDATI RARENDA 006695Approved Prior to Jan 1, 1982

Listed patents (6)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8501819Mar 07, 20263 mo ago
U-1427
8450375Mar 07, 20263 mo ago
Product
8501818Mar 07, 20263 mo ago
Product
7838564Mar 07, 20263 mo ago
Product
9382191Mar 07, 20263 mo ago
Product
7872050Jul 08, 2029in 3 yr 1 mo
U-1427

Mechlorethamine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.